MELVILLE, N.Y.—Chyron has unveiled version 1.8 of PRIME VSAR. The new version is designed to radically simplify virtual production by merging the cutting-edge graphics of Epic Games' Unreal Engine 4 ...

Friday turned out to be a nightmare for Versartis Inc (NASDAQ:VSAR) investors, after the drug maker reported negative Phase 3 VELOCITY data in pediatric GHD patients. In the pivotal study, treatment ...

MELVILLE, N.Y.—Chyron today released PRIME VSAR 1.7, which implements Unreal Engine 4.26, increases cameras per PRIME VSAR engine and adds new template-based tools to simply creating and managing ...

Before we spend days researching a stock idea we’d like to take a look at how hedge funds and billionaire investors recently traded that stock. S&P 500 Index returned about 5.2% during the last 12 ...

As of late, it has definitely been a great time to be an investor in Versartis Inc VSAR. The stock has moved higher by 7.9% in the past month, while it is also above its 20 Day SMA too. This ...

At the 2025 NAB Show, Chyron is showcasing the latest 2.1 release of PRIME VSAR – an Unreal based virtual set and augmented reality engine that is tailored to empower producers to easily leverage ...

With general bullishness amongst the heavyweights, key money managers have been driving this optimism. Ardsley Partners, led by Philip Hempleman, created the most valuable position in Versartis Inc ...

VSAR, an endocrine-focused biopharmaceutical firm in the process of developing a treatment for growth hormone deficiency, plans to raise $80.5 million in its upcoming IPO. VSAR will offer 4.6 million ...

Benchmark raised its EBAY price target to $45 from $40, but at last check, the stock was trading 0.3% lower at $38.13. The online auction site operator is cooling its heels after touching a record ...

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their ...